Insta
Gujarat: Bharat Biotech Begins Commercial Roll Out Of Covaxin From New Facility In Ankleshwar
Source: Financial Express
In a big boost towards augmenting the production capacity of the nation's first indigenously developed COVID-19 vaccine Covaxin, Hyderabad-based Bharat Biotech has rolled out the first commercial batch from its Chiron Behring Vaccines facility in Gujarat's Ankleshwar, reports Times of India.
With the production having begun at the facility which was built during 2020, supplies will now begin from here in September. It should be noted that the production had begun there in early June itself, before which the team from Bharat Biotech had executed engineering batches to study the equipment functionality at the facility.
The first batch was launched by Union Minister for Health and Family Welfare Mansukh Mandaviya.
Covaxin, along with Covishield has been widely used as a part of the Government's nationwide COVID-19 vaccination programme so far. It has been developed by Dr Krishna Ella-led Bharat Biotech in association with the Indian Council for Medical Research (ICMR) and Pune-based National Institute of Virology.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.
Latest
